Demir Aysin, Yarali Nese, Fisgin Tunc, Duru Feride, Kara Abdurrahman
Dr Sami Ulus Children's Hospital, Ankara, Turkey.
J Trop Pediatr. 2004 Dec;50(6):369-71. doi: 10.1093/tropej/50.6.369.
Increased levels of transferrin receptors (TfR) and soluble TfR (sTfR) are reliable indicators of iron deficiency anemia and conditions with enhanced erythropoietic activity. In this study we measured sTfR levels in the cases of beta-thalassemia trait (betaTT) and IDA to see whether it would be a diagnostic tool for the differentiation of betaTT and IDA. On the other hand STfR levels could give an idea about erythropoietic activity in betaTT. Serum transferrin receptor (sTfR) levels were measured with enzyme immune assay in 37 cases with betaTT, in 26 patients with iron deficiency anemia (IDA), in 17 patients with the coexistence of betaTT with IDA, and in 21 healthy controls. Mean sTfR in betaTT (6.54 +/- 1.88) were statistically higher than in controls (5.09 +/- 0.76) and lower than in IDA (11.46 +/- 5.03) and in IDA coexistence with betaTT (14.44 +/- 5.3, p < 0.05 in each comparison). However, in 17 cases with betaTT sTfR levels showed an overlap between the patients with IDA, and in 15 cases with betaTT it also showed an overlap with controls. The finding of higher sTfR levels in betaTT compared with controls suggested that there was a degree of ineffective hematopoiesis in betaTT. Although sTfR levels in IDA were higher than in betaTT, because of largely overlapping values in both groups, it was not satisfactory to distinguish betaTT from IDA.
转铁蛋白受体(TfR)和可溶性转铁蛋白受体(sTfR)水平升高是缺铁性贫血及红细胞生成活性增强情况的可靠指标。在本研究中,我们检测了β地中海贫血特征(βTT)和缺铁性贫血(IDA)患者的sTfR水平,以观察其是否可作为鉴别βTT和IDA的诊断工具。另一方面,sTfR水平可以反映βTT中的红细胞生成活性。采用酶免疫分析法检测了37例βTT患者、26例缺铁性贫血(IDA)患者、17例βTT合并IDA患者及21名健康对照者的血清转铁蛋白受体(sTfR)水平。βTT患者的平均sTfR水平(6.54±1.88)在统计学上高于对照组(5.09±0.76),低于IDA患者(11.46±5.03)及βTT合并IDA患者(14.44±5.3,各比较组p<0.05)。然而,17例βTT患者的sTfR水平在IDA患者中有重叠,15例βTT患者的sTfR水平与对照组也有重叠。βTT患者sTfR水平高于对照组的结果提示βTT存在一定程度的无效造血。虽然IDA患者的sTfR水平高于βTT患者,但由于两组数值大量重叠,用其区分βTT和IDA并不理想。